NCT02550262View on ClinicalTrials.gov

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Labor Pain
Interventions
DRUG

Bupivacaine

0.0625% Bupivacaine plus fentanyl 2mcg/ml

DRUG

Fentanyl

0.0625% Bupivacaine plus fentanyl 2mcg/ml

DEVICE

Infusion pump

Infusion pump set to deliver programmed intermittent epidural boluses (PIEB) plus patient-controlled epidural analgesia (PCEA).

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT02550262 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor | Biotech Hunter | Biotech Hunter